R&D
MDS
GMP & PIPELINE
PRODUCT
PUBLICATIONS
INVESTORS
DISCLOSURES
FINANCES
STOCK PRICE
INVESTORS RELATIONS
PEOPLEBIO
ENGLISH
KOREAN
ENGLISH
KOREAN
R&D
MDS
GMP & PIPELINE
PRODUCT
PUBLICATIONS
INVESTORS
DISCLOSURES
FINANCES
STOCK PRICE
INVESTORS RELATIONS
PEOPLEBIO
PUBLICATIONS
PeopleBio is continuously publishing peer-reviewed research.
PUBLICATIONS
2021
Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer’s Disease
Pyun JM, Kang MJ, Ryoo NY, Suh JW, Youn YC, Park YH, Kim SY
2021
Endogenous Aβ peptide promote Aβ oligomerization tendency of spiked synthetic Aβ in Alzheimer's disease plasma
Choi YK, Joh YC, Ryu JS, Kim K, Seo D, Kim SY
2020
Blood Amyloid-β Oligomerization as a Biomarker of Alzheimer’s Disease: A Blinded Validation Study
Youn YC, Lee BS, Kim GJ, Ryu JS, Lim K, Lee R, Suh J, Park YH, Pyun JM, Ryu N, Kang MJ, Kim HR, Kang S, An SSA, Kim SY
2020
Association of Plasma Oligomerized Beta Amyloid with Neurocognitive Battery Using Korean Version of Consortium to Establish a Registry for Alzheimer’s Disease in Health Screening Population
Lee JJ, Choi Y, Chung S, Yoon DH, Choi SH, Kang S, Seo D, Park K
2019
Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease
Xue Meng, Tao Li, Xiao Wang, Xiaozhen Lv, Zhiyu Sun, Zhang J, Feng Su, Kang S, Kim SY, An SSA, Xin Yu, Chen Zhang, Huali Wang
01
02
03
04
05